Literature DB >> 22180519

Analysis of cell binding and internalization of multivalent PEG-based gene delivery vehicles.

Nicole M Moore1, Shelly E Sakiyama-Elbert.   

Abstract

RGD peptides have been incorporated into several gene delivery vehicles to enhance specific interactions of nonviral vehicles with the cell surface. However, there are contradictory results regarding the effect of linear RGD peptides on specific cell surface binding of polyethylene glycol (PEG)-conjugated gene delivery vehicles. This study sought to understand how coupling RGD peptides to PEG vehicles affects cell binding and internalization using a novel four arm PEG backbone. Coupling multiple RGD peptides to the PEG backbone increased the affinity of the vehicle for the cell surface, and that the PEG backbone did not reduce the affinity of RGD peptides for integrin receptors in both kinetic and equilibrium studies. Kinetic studies suggest that cellular internalization of PEG-based vehicles is not regulated by the RGD peptides on the vehicle, but rather by nonspecific interactions with heparan sulfate proteoglycans either alone or in combination with integrins. These results suggest that while increasing the number of RGD peptides per vehicle increases cell binding, but it does not contribute to increased internalization or transfection efficiency.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22180519     DOI: 10.1109/TNB.2011.2179555

Source DB:  PubMed          Journal:  IEEE Trans Nanobioscience        ISSN: 1536-1241            Impact factor:   2.935


  2 in total

Review 1.  Engineering therapies in the CNS: what works and what can be translated.

Authors:  Andrew J Shoffstall; Dawn M Taylor; Erin B Lavik
Journal:  Neurosci Lett       Date:  2012-02-04       Impact factor: 3.046

Review 2.  Overcoming barriers in non-viral gene delivery for neurological applications.

Authors:  Aaron Tasset; Arjun Bellamkonda; Wenliang Wang; Ilya Pyatnitskiy; Deidra Ward; Nicholas Peppas; Huiliang Wang
Journal:  Nanoscale       Date:  2022-03-10       Impact factor: 8.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.